Evdokia F. Luginova
Research Subjects
Evdokia F. Luginova has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
D. A. Nikolaeva
Scientific and Practical Center “Phthisiology
1 shared publicationE. A. Nikiforova
Perinatal Center of the Republican Hospital No 1
1 shared publication- E. N. Dolzhenko
Ryazan Regional Clinical TB Dispensary
1 shared publication O. I. Guryeva
Scientific and Practical Center “Phthisiology
1 shared publication- Olga D. Baronova
Moscow Regional Clinical TB Dispensary; M.F. Vladimirsky Moscow Regional Research Clinical Institute
1 shared publication - Valentina A. Aksenova
National Medical Research Center of Phthisiopulmonology and Infectious Diseases; I. M. Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication
Latest Publications
- Open Access
- 17 January 2023
- Published by Pacific State Medical University in Pacific Medical Journal
- No. 4,p. 88-91
A case of tuberculosis in a premature newborn with faborable outcome
This paper presents a clinical case of a favorable tuberculosis chemotherapy outcome in a premature newborn. The role of early diagnosis in the development and outcome of the disease is shown. The newborn had no specific symptoms and clinical signs of tuberculosis. Therefore, when signs of an infectious disease appear in newborns, account should be taken of the mother’s medical history and the results of her fluorographic examination after childbirth. A favorable outcome can be achieved by timely separation of newborns from infected mothers, prompt commencement of specific chemotherapy, and patient management by phthisiatricians, neonatologists, and resuscitators.
- 17 January 2023
- Published by Pacific State Medical University in Pacific Medical Journal
- No. 4,p. 88-91
Open AccessA case of tuberculosis in a premature newborn with faborable outcome
This paper presents a clinical case of a favorable tuberculosis chemotherapy outcome in a premature newborn. The role of early diagnosis in the development and outcome of the disease is shown. The newborn had no specific symptoms and clinical signs of tuberculosis. Therefore, when signs of an infectious disease appear in newborns, account should be taken of the mother’s medical history and the results of her fluorographic examination after childbirth. A favorable outcome can be achieved by timely separation of newborns from infected mothers, prompt commencement of specific chemotherapy, and patient management by phthisiatricians, neonatologists, and resuscitators.
- Open Access
- 10 September 2022
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 100 (8) , 31-36
The Use of Rifapentine for Preventive Chemotherapy in Children from Risk Groups of Developing Tuberculosis
The objective: to compare efficacy of preventive treatment of children with latent tuberculosis infection using various regimens of anti-tuberculosis drugs and assess the risk of adverse events to these drugs.Subjects and Methods. 117 children of 2-17 years old with latent tuberculosis infection [a positive result of the test with tuberculous recombinant allergen (TRA)] were enrolled in the prospective study. They received preventive treatment with the regimen containing isoniazid and rifapentine. The comparison group included 84 children who received isoniazid and rifampicin.Results. In terms of safety and efficacy of chemotherapy regimens in the study, the best results were obtained when using the regimen containing isoniazid and rifapentine: the therapy was well tolerated, hepatotoxic reactions were registered in 1.7% of children. After a full course of preventive treatment in 24 months of follow-up, there was a statistically significant decrease in the proportion of hyperergic results of the skit test with TRA from 44 (41.9%) to 0 (0%) χ2 McNemar 43.00; p < 0.01; and conversion of the TRA test result from positive to negative was observed in 18.1% of children.
- 10 September 2022
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 100 (8) , 31-36
Open AccessThe Use of Rifapentine for Preventive Chemotherapy in Children from Risk Groups of Developing Tuberculosis
The objective: to compare efficacy of preventive treatment of children with latent tuberculosis infection using various regimens of anti-tuberculosis drugs and assess the risk of adverse events to these drugs.Subjects and Methods. 117 children of 2-17 years old with latent tuberculosis infection [a positive result of the test with tuberculous recombinant allergen (TRA)] were enrolled in the prospective study. They received preventive treatment with the regimen containing isoniazid and rifapentine. The comparison group included 84 children who received isoniazid and rifampicin.Results. In terms of safety and efficacy of chemotherapy regimens in the study, the best results were obtained when using the regimen containing isoniazid and rifapentine: the therapy was well tolerated, hepatotoxic reactions were registered in 1.7% of children. After a full course of preventive treatment in 24 months of follow-up, there was a statistically significant decrease in the proportion of hyperergic results of the skit test with TRA from 44 (41.9%) to 0 (0%) χ2 McNemar 43.00; p < 0.01; and conversion of the TRA test result from positive to negative was observed in 18.1% of children.
- Open Access
- 30 November 2018
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 7 (4) , e0416
Tuberculosis among pediatric population in the Extreme North of Russia
Introduction Fight against tuberculosis (TB) or TB control is still among the world’s major objectives, and, as such, is driving the main focus areas of global public health [1]. The action planning by health services is based on clear understanding of the TB prevalence. Accumulation and analysis of key epidemiologic indicators describing the scale and size of the problem of TB serves as yet another mechanism, using which the spread of TB can be further contained within a region, a country, or the world [2].
- 30 November 2018
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 7 (4) , e0416
Open AccessTuberculosis among pediatric population in the Extreme North of Russia
Introduction Fight against tuberculosis (TB) or TB control is still among the world’s major objectives, and, as such, is driving the main focus areas of global public health [1]. The action planning by health services is based on clear understanding of the TB prevalence. Accumulation and analysis of key epidemiologic indicators describing the scale and size of the problem of TB serves as yet another mechanism, using which the spread of TB can be further contained within a region, a country, or the world [2].